News
LENZ Therapeutics recently received FDA approval for its Vizz eye drops to treat presbyopia in adults, offering a new non-surgical solution for age-related farsightedness. This regulatory milestone ...
NDTV Profit on MSN6d
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod
The US FDA approval of Vizz was based on results from three randomised, double-masked, controlled Phase 3 studies.
KTVU FOX 2 San Francisco on MSN3d
New FDA approved eye drops for vision is coming soon
A California company has created a first-of-its-kind eyedrop that corrects a certain type of vision impairment and could ...
Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...
Treats a common eye condition The product is called VIZZ, and it specifically targets a common condition known as presbyopia, an age-related decline that causes blurry near vision.
Stars Insider on MSN23h
Clear vision without glasses: new eye drops approved for presbyopia
FDA greenlights VIZZ, the first daily eye drops to restore near vision for adults with age-related blurry vision ...
Lenz Therapeutics Inc., has recently received approval from the US Food and Drug Administration for Vizz eye drop to treat presbyopia in adults. Vizz aceclidine ophthalmic solution 1.44% is the first ...
Find the latest LENZ Therapeutics, Inc. (LENZ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback